← Back to Search

Behavioral Intervention

Hypnotic Cognitive Therapy (HYPNOCT) for Spinal Cord Injury

N/A
Waitlist Available
Led By Charles Bombardier, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed via telephone interview at baseline prior to randomization, and at 6 and 12 weeks following randomization.
Awards & highlights

Study Summary

The Efficacy of Hypnotic Cognitive Therapy for Chronic Pain in SCI

Eligible Conditions
  • Spinal Cord Injury
  • Chronic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed via telephone interview at baseline prior to randomization, and at 6 and 12 weeks following randomization.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed via telephone interview at baseline prior to randomization, and at 6 and 12 weeks following randomization. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Average Pain Intensity
Secondary outcome measures
Change in Community Participation
Change in Depression
Change in Global Improvement Treatment Satisfaction
+7 more

Side effects data

From 2020 Phase 4 trial • 133 Patients • NCT03075501
6%
Dry mouth
2%
Shakiness/Trembling
2%
Heart racing
1%
High heart rate and blood pressure
100%
80%
60%
40%
20%
0%
Study treatment Arm
20mg Methamphetamine
0mg Methamphetamine (Placebo)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hypnotic Cognitive Therapy (HYPNOCT)Experimental Treatment1 Intervention
The HYPNOCT arm will use hypnotic strategies and suggestions for identifying adaptive cognitions and for making adaptive changes in cognitions more integrated into the participant's belief system (note that traditional CT uses purposeful argument and logic to make these changes; in this condition the investigators add a hypnotic automaticity to this process). Thus, HYPNOCT is a hybrid intervention that overlaps with both hypnosis and CT. The participant will relax in a comfortable position and listen to the clinician speak. However, unlike standard hypnosis for pain, the post-induction suggestions will focus on changes in cognitive content and processes (as opposed to changes in sensory experience). The participants will undergo 6 weekly sessions each lasting 30-40 minutes.
Group II: Usual CareActive Control1 Intervention
The study therapist will notify participants assigned to Usual Care via the participant's preferred mode of communication (phone, U.S. mail, or email). People assigned to usual care will be encouraged to continue using the health care services available to them to address their pain. The study therapist will emphasize the importance of completing the outcome assessments. The treatments usual care participants actually received will be assessed at 6 and 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hypnotic Cognitive Therapy (HYPNOCT)
2019
N/A
~130

Find a Location

Who is running the clinical trial?

The Craig H. Neilsen FoundationOTHER
54 Previous Clinical Trials
2,766 Total Patients Enrolled
University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,222 Total Patients Enrolled
Charles Bombardier, PhDPrincipal Investigator - University of Washington
University of Washington
3 Previous Clinical Trials
371 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~21 spots leftby Apr 2025